|
|
|
Settlement agreed in NHS drugs case |
|
|
|
Tuesday, 04 March 2008 |
Scottish ministers and health boards have reached settlement with a major international pharmaceutical company on alleged anti-competitive cartel conduct in connection with the supply of drugs to the NHS.
Goldshield Group, Goldshield Pharmaceuticals and Forley Generics have
agreed, without admitting liability, to pay £750,000 in compensation
and to provide co-operation in connection with continuing civil claims
against a number of other companies regarding alleged price fixing
arrangements for a number of generic drugs.
Cabinet Secretary for Health and Wellbeing Nicola Sturgeon said: "I am
delighted that we have managed to reach a settlement agreement with
Goldshield. This is a satisfactory conclusion to our negotiations."
Goldshield Group chairman Keith Hellawell said: "We recognise the
importance of building strong working relationships with our customers.
We view the NHS as a valued customer and are therefore very pleased
with today's settlement."
In February 2005, Scottish ministers and health boards lodged claims in
the civil courts in England against a number of companies, in
connection with forming alleged price-fixing cartels involving
Warfarin, Ranitidine and Penicillin-based drugs.
Goldshield Group, Goldshield Pharmaceuticals and Forley Generics have
already settled a similar claim with the Department of Health in
England.
No one has commented on this article.
Related news items:
|
Featured sites
Wise Group
The Wise Group is a leading social enterprise that works with others to make a positive difference to the lives of individuals, the communities in which they live and the society to which they belong. We assist unemployed people into sustainable employment through our innovative support, training and work experience programmes. We also contribute to the sustainable development of communities through programmes that regenerate local environments.
Click here to visit this site
Site news...
Have your say: We have introduced a comments system in our news and magazine article sections, submit your comments for approval. Your comments will feature in the "Your comments" section.
|
|
|
Holyrood news 
